Marie Bosslett, Assistant Editor

Almirall is pioneering a holistic approach in dermatology, emphasizing psychological well-being through the WHO-5 index in clinical trials.

In case you missed it, this week we had news about denifanstat's promising phase 3 results for acne, emerging therapies in lichen planus, initial insights from RAD 2025, and more.

At RAD 2025, Eli Lilly revealed promising results for lebrikizumab in treating atopic dermatitis in patients with skin of color.

Discover groundbreaking insights from the RAD 2025 conference on roflumilast's potential to transform treatment for infant atopic dermatitis.

Arcutis Biotherapeutics showcases promising long-term results of Zoryve for atopic dermatitis in young children at RAD 2025, emphasizing safety and efficacy.

The OS-01 peptide formulation enhanced skin barrier function and reduced inflammation, showing promising results in a 12-week clinical trial.

Tristan Hasbargen, PA-C, led a hands-on suturing workshop at the Fall Clinical NP/PA Conference, enhancing skills in surgical dermatology.

The National Psoriasis Foundation Seal of Recognition program has expanded to prescription drugs, making roflumilast the first to achieve the indication.

Explore cutting-edge insights and networking opportunities at this year's Fall Clinical Dermatology Conference for PAs and NPs, focusing on dermatology education and innovative treatments.

Catch up on coverage from the last day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

Heather Gates, PA-C, shares insights on the importance of continuous learning, mentorship, and legislative reform for PAs and NPs in dermatology.

Evan Rieder, MD, shares effective strategies to enhance dermatology practice efficiency by addressing psychological aspects of patient care and setting professional boundaries.

Catch up on coverage from the third day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

Discover innovative strategies for AK treatment from Darrell Rigel, MD, MS, at the latest Fall Clinical PA/NP conference.

Discover the latest advancements in aesthetics as Heather Gates, PA-C, shares innovative techniques and emerging technologies from this groundbreaking workshop.

Catch up on coverage from the second day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

At this year's Fall Clinical PA/NP meeting, Darrell Rigel, MD, MS, spoke about the evolving role of GEP in managing melanoma and squamous cell carcinoma.

Catch up on coverage from the first day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

In her presentation at Fall Clinical NP/PA, Heather Gates, PA-C, shared how professionals can enhance their practice using AI and social media, fostering authenticity and patient trust in a digital age.

Explore the latest insights, strategies, and treatments for patients with skin cancer as Dermatology Times looks back on Melanoma and Skin Cancer Awareness Month.

Shannon Humphrey, MD, leads a shift in aesthetic dermatology towards patient empowerment and self-care, supported by Merz Aesthetics' Pillars of Confidence study.

Amanda Caldwell, MSN, APRN-C, is fostering community and collaboration for NPs and PAs as the new president of the SDNP.

Peter Graylin shares his transformative skin cancer journey, emphasizing the importance of early detection, sun safety, and accessible dermatology programs.

Amanda Caldwell, MSN, APRN-C, is promoting accessibility, education, and relatability as the newly inducted president of the Society for Dermatology Nurse Practitioners.

Christopher G. Bunick, MD, PhD, presents the significant challenges of CHE due to a lack of FDA-approved treatments, impacting patients' quality of life and requiring better therapeutic options.

Sarah Allen, MD's Skin Clique has launched a virtual Esthetician Program, providing personalized skincare consultations and bridging access to expert guidance for all patients.

In case you missed it, this week we had news about the FDA's approval of Arcutis' roflumilast for plaque psoriasis, cold plasma technology for acne-prone skin, azathioprine for the long-term treatment of alopecia, and more.

As melanoma rates rise, Victor Gall, MD, emphasizes proactive care, early detection, and innovative treatments to improve patient outcomes and survival rates.

A recent analysis reveals safety profiles of apremilast and deucravacitinib for psoriasis, highlighting unique adverse events and long-term monitoring needs.

A recent study reveals that combining topical anti-aging products with Thermage enhances skin hydration and reduces fine lines for lasting results.